About Elekta

Through precision radiation medicine, Elekta is helping clinicians focus where it matters, empowering them to protect the moments that matter for their patients.

Our legacy of innovation drives us forward

For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone with cancer in the world has access to – and benefits from – more precise, personalized radiotherapy treatments. Our solutions for cancer care and brain disorders are tailored to target the tumor and protect the patient.

“Prof. Lars Leksell (1907 – 1987) is the inventor of radiosurgery and developer of the advanced radiosurgical platform that bears his name, Leksell Gamma Knife®. Elekta was founded by Lars Leksell almost 50 years ago.”

Access for all

For Elekta, Precision Radiation Medicine means delivering globally accessible, precise and personalized radiation therapy that targets the tumor and protects the patient. Leveraging the intelligence of information-guided care, our radiotherapy can quickly respond and adapt to changing tumor shape, position and biology, all within a streamlined treatment plan.

Find out more about our headquarters and global locations, the management team, career opportunities and investor relations on elekta.com. Click here to contact us directly.

1. Cancer Research UK – cancer statistics. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer#heading-Zero
Last accessed: September 2018.
2. WHO cancer factsheet. Available from: http://www.who.int/en/news-room/fact-sheets/detail/cancer Last accessed: September 2018.
3. Cancer Research - Advancing Care, Advancing Years. Available from: https://www.cancerresearchuk.org/sites/default/files/advancing_care_advancing_years
Last accessed: September 2018.
4. Lievens Y, et al. Radiother and Oncol 2017;125:175-177.
5. Atun R, et al. Lancet Oncol Commission 2015; 16(10): 1153-1186. Date of preparation: September 2018.